SCHEMBL728168

SCHEMBL728168

Bc1ccnc(C(=O)OC(C)(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 13/20 0.48
GABRB3 P28472 13/20 0.48
GABRA1 P14867 12/20 0.48
GABRA2 P47869 12/20 0.48
GABRA5 P31644 12/20 0.48
GABRA3 P34903 11/20 0.48
GABRA6 Q16445 10/20 0.48
GABRA4 P48169 5/20 0.48
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRB2 P47870 1/20 0.48
GABRE P78334 1/20 0.48
GABRG1 Q8N1C3 1/20 0.48
GABRG3 Q99928 1/20 0.48
GABRQ Q9UN88 1/20 0.48
HPGDS O60760 1/20 0.39
AR P10275 1/20 0.37
ATR Q13535 1/20 0.37
RAF1 P04049 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13105640 0.81 GABRG2 (0.46) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL163615 0.81 GABRG2 (0.46) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL29563011 0.81 GABRG2 (0.46) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL3700486 0.81 GABRG2 (0.46) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL724883 0.80 ALDH1A1 (0.50) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL9979936 0.80 GABRG2 (0.56) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL3882564 0.80 GABRG2 (0.45) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL15114586 0.80 KDM4E (0.56) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL31364143 0.79 FTO (0.61) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL16976879 0.77 CYP1A2 (0.50) GABRG2GABRB3GABRA1GABRA2GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003544-A1 PROTEIN KINASE INHIBITORS AND METHODS OF TREATMENT THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2012-01-12 WO disclosed